Immunity to COVID-19 is much more interesting and much more complicated than simply something you do or do not have. Kathryn Cleary spoke to two experts about what we know about COVID-19 immunity and the implications of that for antibody testing and the development of vaccines.
Scientific research on COVID-19 has been published at an unprecedented scale and speed, but some fear that this is at the cost of scientific rigour. Adele Baleta explores the pros and cons of high-speed science.
South African researchers are poised to start enrolling patients in a landmark international clinical trial which will compare the safety and effectiveness of four different drugs or drug combinations against COVID-19.
South Africa’s strategy to defeat COVID-19 (Coronavirus Disease 2019) is to lockdown the country and upscale testing to quickly identify individuals who may have been infected with the SARS-CoV-2 virus.